Related Experiment Videos
Inhibition of lung homing of B16F10 by pentoxifylline, a microfilament depolymerizing agent
1Chemotherapy and Stem Cell Biology Division, Cancer Research Institute, Bombay, India.
Abstract:
B16 melanoma has proved to be an ideal model for investigating metastasis. The parental B16F1 line grows as a localized subcutaneous tumor in C57BL/6 or DBA/2 mice. However, by means of successive intravenous transplantation, a subline B16F10 has been established. This shows preponderant lung homing when transplanted by intravenous route into C57BL/6 mice. In this paper we have shown that pentoxifylline (PTX; Hoechst), a microfilament depolymerising agent can inhibit significantly this lung homing of B16F10 cells. It also had a marginal inhibitory effect on subcutaneous tumor growth.
Insights
Pentoxifylline (PTX) significantly inhibits lung metastasis of B16F10 melanoma cells in mice. This microfilament-disrupting agent offers a potential therapeutic strategy for reducing cancer spread.
Area of Science:
- Oncology
- Cancer Metastasis Research
- Pharmacology
Background:
- B16 melanoma is a widely used model for studying cancer metastasis.
- The B16F10 cell line exhibits significant lung homing after intravenous transplantation in mice.
- Understanding mechanisms of cancer cell homing is crucial for developing anti-metastatic therapies.
Purpose of the Study:
- To investigate the effect of pentoxifylline (PTX) on the lung homing of B16F10 melanoma cells.
- To evaluate PTX's potential as an inhibitor of cancer metastasis.
Main Methods:
- Utilized the B16F10 melanoma cell line in a mouse model (C57BL/6 mice).
- Administered pentoxifylline (PTX), a microfilament depolymerising agent.
- Assessed the effect of PTX on lung homing following intravenous transplantation.
- Evaluated PTX's impact on subcutaneous tumor growth.
Main Results:
- Pentoxifylline (PTX) significantly inhibited the lung homing of B16F10 melanoma cells.
- PTX demonstrated a marginal inhibitory effect on subcutaneous B16F10 tumor growth.
- The findings suggest PTX interferes with the metastatic process.
Conclusions:
- Pentoxifylline (PTX) effectively reduces lung metastasis of B16F10 melanoma cells.
- PTX's mechanism involves interfering with cellular processes critical for metastasis.
- This study highlights PTX as a potential therapeutic agent for managing melanoma metastasis.